Atopic Dermatitis: Updates on Pathophysiology and Management

Atopic dermatitis (atopic eczema) is a chronic relapsing and remitting inflammatory skin disease affecting one in 10 people in their lifetime. Atopic dermatitis is caused by a complex interaction of immune dysregulation, epidermal gene mutations, and environmental factors that disrupts the epidermis causing intensely pruritic skin lesions. Repeated scratching triggers a self-perpetuating itch-scratch cycle, which can have a significant impact on the patient's quality of life. The American Academy of Dermatology has created simple diagnostic criteria based on symptoms and physical examination findings. Maintenance therapy consists of liberal use of emollients and daily bathing with soap-free cleansers. Use of topical corticosteroids is the first-line treatment for atopic dermatitis flare-ups. Pimecrolimus and tacrolimus are topical calcineurin inhibitors that can be used in conjunction with topical corticosteroids as first-line treatment.

    Related Conference of Atopic Dermatitis: Updates on Pathophysiology and Management

    November 17-18, 2025

    8th International Dermatology Conference: Skin and Body

    Paris, France
    February 05-06, 2026

    9th Annual Conference on Skin Cancer and Dermatology

    Paris, France
    May 07-08, 2026

    9th World Cosmetic and Dermatology Congress

    Paris, France
    June 22-23, 2026

    28th World Dermatology and Aesthetic Congress

    London, UK
    August 25-26, 2026

    26th European Dermatology Congress

    Paris, France

    Atopic Dermatitis: Updates on Pathophysiology and Management Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in